MARKET

NVAX

NVAX

Novavax Inc
NASDAQ
8.25
+0.38
+4.83%
After Hours: 8.17 -0.08 -0.97% 19:59 02/06 EST
OPEN
8.01
PREV CLOSE
7.87
HIGH
8.31
LOW
7.85
VOLUME
3.25M
TURNOVER
--
52 WEEK HIGH
10.64
52 WEEK LOW
5.01
MARKET CAP
1.34B
P/E (TTM)
4.587
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NVAX last week (0126-0130)?
Weekly Report · 6d ago
Pfizer Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Benzinga · 6d ago
Novavax’s Matrix-M Licensing Deal With Pfizer Could Be A Game Changer For Novavax (NVAX)
Simply Wall St · 02/01 17:23
Assessing Novavax’s (NVAX) Valuation After Its New Matrix M Licensing Agreement With Pfizer
Simply Wall St · 01/31 07:29
Novavax Inc. Stock Slides 6.3%, Underperforms Peers
Dow Jones · 01/30 21:34
Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today?
Seeking Alpha · 01/30 15:09
Novavax (NVAX) Gets a Sell from Bank of America Securities
TipRanks · 01/30 13:26
Citi Keeps Their Sell Rating on Novavax (NVAX)
TipRanks · 01/30 11:26
More
About NVAX
Novavax, Inc. is a biotechnology company. It is focused on addressing global health challenges through its vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M adjuvant. Matrix-M can be used to create vaccines for a variety of diseases to help tackle some of the pressing health challenges. Its proprietary Matrix-M adjuvant, when added to vaccines, has been shown to help induce a stronger and longer-lasting immune response. Its recombinant protein-based nanoparticle technology has been shown to be highly immunogenetic. Its technology platform is used in its authorized COVID-19 vaccine and the R21/Matrix-M adjuvant malaria vaccine. Its late-stage programs include a COVID-19-Influenzavaccine candidate, and an influenza vaccine candidate. R21/Matrix-M adjuvant malaria vaccine, a malaria vaccine developed by its partner. It provides Matrix-M adjuvant for use in various programs in preclinical and clinical stage, and preclinical investigations.

Webull offers Novavax Inc stock information, including NASDAQ: NVAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVAX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVAX stock methods without spending real money on the virtual paper trading platform.